George Lawrence Mikan III Sells 31,798 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 31,798 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34. Following the completion of the transaction, the chief executive officer now owns 146,539 shares in the company, valued at approximately $1,074,130.87. This trade represents a 17.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Stock Up 0.7 %

Shares of NYSE:NEUE opened at $7.45 on Friday. The firm has a market cap of $61.72 million, a P/E ratio of -0.15 and a beta of 0.57. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $16.59. The company’s 50-day moving average price is $5.56 and its two-hundred day moving average price is $5.40.

Institutional Trading of NeueHealth

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. NEA Management Company LLC acquired a new position in shares of NeueHealth during the second quarter valued at $14,834,000. Deer Management Co. LLC bought a new stake in NeueHealth during the 2nd quarter worth about $5,436,000. Partners Group Holding AG acquired a new position in NeueHealth during the 3rd quarter valued at about $463,000. Finally, Renaissance Technologies LLC bought a new position in shares of NeueHealth in the 2nd quarter valued at about $312,000. Institutional investors and hedge funds own 63.88% of the company’s stock.

Analyst Ratings Changes

Separately, Royal Bank of Canada dropped their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.

View Our Latest Stock Analysis on NeueHealth

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Articles

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.